Discovering the risks associated with rapid drop in blood glucose
A rapid drop in HbA1c (glycated haemoglobin) can have significant health implications, particularly ...
The safety and effectivity of Noctura 400 is of utmost importance to us. Anna is responsible for Noctura 400 Quality and Regulatory issues, and she ensures that the safety and effectiveness of Noctura 400 has been fully documented in line with relevant medical device regulations. She also ensures that there is a robust Quality framework in place at every manufacturer involved in the production of Noctura 400, so that full traceability is possible in the event of a problem. In the event of a problem, she oversees and documents the investigation and resolution. Anna maintains the CE marking, ISO 13485 certification, MHRA registration and other regulatory requirements.
